1636 материалов по теме, собраны автоматически из проверенных источников
The proportion of U.S. women who have never been screened for cervical cancer increased at a “troubling” rate over the past couple decades, according to researchers. As recently as a few years ago, nearly one-third of women aged 21 to 29 years reported never having been screened, results of a cross-sectional study…
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer PR Newswire
Kazia Therapeutics Announces First Patient Dosed in PNOC035 Clinical Study Evaluating Paxalisib for Recurrent Pediatric AT/RT Brain Cancer PR Newswire
No approved treatments exist for returning brain cancer in children. Kazia starts a trial. Stock Titan
Pyxis Oncology Announces Positive Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma... markets.businessinsider.com
A cancer treatment showed disease control in 94% of trial patients. Pyxis plans a roughly 500-patient trial. Stock Titan
"Your participation in the Terry Fox Run makes you a research partner," says cancer researcher Dr. Sachin Katyal DiscoverWestman
Naples Takes Center Stage in Cancer Research Il Mattino
New research indicates that people with invasive cancer face an elevated risk of experiencing a stroke, especially in the first few months after diagnosis and if they have certain types of cancer. The findings are published online by Wiley in Cancer.
Veru Advances Oral Sabizabulin Following Positive Preclinical Data Showing Potent Anticancer Activity in Human Daraxonrasib ) Resistant Pancreatic Cancer into a Planned Phase 2 Clinical Trial Investing News Network
Penn startup launches first human trial for solid tumor cancer treatment The Daily Pennsylvanian
Penn startup launches first human trial for solid tumor cancer treatment The Daily Pennsylvanian
MIB Agents OutSmarting Osteosarcoma Research Grants 2027 Oncodaily
Congratulations to Our New CRUK Funded Researchers - Cancer Research UK Science and Innovation Oncodaily
Researchers from Cambridge and Basel have developed small molecules that could make cancer immunotherapies more effective. They work in two ways: they prompt macrophages to engulf cancer cells and alter the surrounding tissue, reducing its ability to suppress immune attacks on the tumor.